• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在跨膜通道处靶向肿瘤细胞与巨噬细胞之间的集落刺激因子-1信号传导可抑制乳腺癌扩散。

Targeting CSF-1 signaling between tumor cells and macrophages at TMEM doorways inhibits breast cancer dissemination.

作者信息

Duran Camille L, Surve Chinmay R, Ye Xianjun, Chen Xiaoming, Lin Yu, Harney Allison S, Wang Yarong, Sharma Ved P, Stanley E Richard, Cox Dianne, McAuliffe John C, Entenberg David, Oktay Maja H, Condeelis John S

机构信息

Integrated Imaging Program for Cancer Research, Albert Einstein College of Medicine, Bronx, NY, USA.

Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Oncogene. 2025 Jul 11. doi: 10.1038/s41388-025-03485-y.

DOI:10.1038/s41388-025-03485-y
PMID:40646332
Abstract

Tumor cell intravasation is essential for metastatic dissemination, but its exact mechanism is incompletely understood. We have previously shown that in breast cancer, the direct and stable association of a tumor cell expressing Mena, a Tie2/VEGF macrophage, and a vascular endothelial cell, creates an intravasation portal, called a "tumor microenvironment of metastasis" (TMEM) doorway, for tumor cell intravasation, leading to dissemination to distant sites. The density of TMEM doorways, also called TMEM doorway score, is a clinically validated prognostic marker of distant metastasis in breast cancer patients. Although we know that tumor cells utilize TMEM doorway-associated transient vascular openings to intravasate, the precise signaling mechanisms involved in TMEM doorway function are only partially understood. Using two mouse models of breast cancer and an in vitro assay of intravasation, we report that CSF-1 secreted by the TMEM doorway tumor cell stimulates local secretion of VEGF-A from the Tie2 TMEM doorway macrophage, leading to the dissociation of endothelial junctions between TMEM doorway-associated endothelial cells, supporting tumor cell intravasation. Acute blockade of CSF-1/CSF-1R signaling decreases macrophage VEGF-A secretion as well as TMEM doorway-associated vascular opening, tumor cell trans-endothelial migration, and dissemination. These new insights into signaling events regulating TMEM doorway function should be explored further as treatment strategies for metastatic disease.

摘要

肿瘤细胞内渗对于转移扩散至关重要,但其确切机制尚未完全明确。我们之前已经表明,在乳腺癌中,表达Mena的肿瘤细胞、Tie2/VEGF巨噬细胞和血管内皮细胞之间直接且稳定的关联,为肿瘤细胞内渗创造了一个内渗入口,称为“转移瘤微环境”(TMEM)通道,从而导致肿瘤细胞扩散至远处部位。TMEM通道的密度,也称为TMEM通道评分,是乳腺癌患者远处转移的一项经过临床验证的预后标志物。尽管我们知道肿瘤细胞利用与TMEM通道相关的短暂血管开口进行内渗,但TMEM通道功能所涉及的确切信号传导机制仅得到部分了解。利用两种乳腺癌小鼠模型和一种内渗体外测定法,我们报告称,TMEM通道肿瘤细胞分泌的CSF-1刺激Tie2 TMEM通道巨噬细胞局部分泌VEGF-A,导致TMEM通道相关内皮细胞之间的内皮连接解离,从而支持肿瘤细胞内渗。急性阻断CSF-1/CSF-1R信号传导会降低巨噬细胞VEGF-A分泌以及TMEM通道相关的血管开口、肿瘤细胞跨内皮迁移和扩散。作为转移性疾病的治疗策略,这些关于调节TMEM通道功能的信号事件的新见解应进一步探索。

相似文献

1
Targeting CSF-1 signaling between tumor cells and macrophages at TMEM doorways inhibits breast cancer dissemination.在跨膜通道处靶向肿瘤细胞与巨噬细胞之间的集落刺激因子-1信号传导可抑制乳腺癌扩散。
Oncogene. 2025 Jul 11. doi: 10.1038/s41388-025-03485-y.
2
Signaling events at TMEM doorways provide potential targets for inhibiting breast cancer dissemination.跨膜蛋白(TMEM)通道处的信号转导事件为抑制乳腺癌扩散提供了潜在靶点。
bioRxiv. 2024 Mar 7:2024.01.08.574676. doi: 10.1101/2024.01.08.574676.
3
Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis.利用活体成像和固定组织分析评估转移通道介导的血管通透性与癌细胞播散相关的肿瘤微环境。
J Vis Exp. 2019 Jun 26(148). doi: 10.3791/59633.
4
STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.STAT5 在巨噬细胞中被乳腺癌细胞衍生的因子激活,并调节肿瘤微环境中的巨噬细胞功能。
Breast Cancer Res. 2021 Nov 7;23(1):104. doi: 10.1186/s13058-021-01481-0.
5
Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA.实时成像揭示了由TIE2高表达巨噬细胞衍生的VEGFA刺激的局部、短暂的血管通透性和肿瘤细胞内渗。
Cancer Discov. 2015 Sep;5(9):932-43. doi: 10.1158/2159-8290.CD-15-0012. Epub 2015 Aug 12.
6
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy.评估磁共振成像以估计转移扩散风险及化疗的促转移作用。
NPJ Breast Cancer. 2022 Sep 2;8(1):101. doi: 10.1038/s41523-022-00463-5.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.TIE2激酶抑制剂瑞巴斯替尼联合紫杉醇或艾瑞布林用于HER2阴性转移性乳腺癌的Ib期临床及药效学研究。
Clin Cancer Res. 2025 Jan 17;31(2):266-277. doi: 10.1158/1078-0432.CCR-24-2464.
10
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.

引用本文的文献

1
Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment.天然免疫细胞和细胞因子在塑造乳腺癌微环境中的双重作用。
Front Immunol. 2025 Aug 20;16:1654947. doi: 10.3389/fimmu.2025.1654947. eCollection 2025.

本文引用的文献

1
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.维莫非尼对比安慰剂治疗腱鞘巨细胞瘤(MOTION):一项多中心、随机、双盲、安慰剂对照的 3 期临床试验。
Lancet. 2024 Jun 22;403(10445):2709-2719. doi: 10.1016/S0140-6736(24)00885-7. Epub 2024 Jun 3.
2
Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.阻断肿瘤来源的集落刺激因子 1(CSF1)可促进免疫许可的肿瘤微环境。
Cancer Immunol Immunother. 2023 Oct;72(10):3349-3362. doi: 10.1007/s00262-023-03496-2. Epub 2023 Jul 28.
3
Macrophages Promote Tumor Cell Extravasation across an Endothelial Barrier through Thin Membranous Connections.
巨噬细胞通过薄的膜状连接促进肿瘤细胞穿过内皮屏障外渗。
Cancers (Basel). 2023 Mar 31;15(7):2092. doi: 10.3390/cancers15072092.
4
Cooperative NF-κB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer.协同 NF-κB 和 Notch1 信号促进乳腺癌中巨噬细胞介导的 MenaINV 表达。
Breast Cancer Res. 2023 Apr 6;25(1):37. doi: 10.1186/s13058-023-01628-1.
5
Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination.活体肿瘤成像显示,在转移扩散过程中,巨噬细胞诱导和 TMEM 介导的肿瘤干细胞富集。
Nat Commun. 2021 Dec 15;12(1):7300. doi: 10.1038/s41467-021-27308-2.
6
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.抗 CSF1 单克隆抗体 Lacnotuzumab(MCS110)联合吉西他滨和顺铂治疗晚期三阴性乳腺癌的随机 II 期研究。
Clin Cancer Res. 2022 Jan 1;28(1):106-115. doi: 10.1158/1078-0432.CCR-20-3955. Epub 2021 Oct 6.
7
Breast Cancer Cell Re-Dissemination from Lung Metastases-A Mechanism for Enhancing Metastatic Burden.乳腺癌细胞从肺转移灶的再播散——增加转移负荷的一种机制
J Clin Med. 2021 May 27;10(11):2340. doi: 10.3390/jcm10112340.
8
The bone microenvironment invigorates metastatic seeds for further dissemination.骨微环境激活转移种子以促进进一步扩散。
Cell. 2021 Apr 29;184(9):2471-2486.e20. doi: 10.1016/j.cell.2021.03.011. Epub 2021 Apr 19.
9
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.一项 CSF-1R 抑制剂 LY3022855 联合度伐利尤单抗或替西木单抗治疗晚期实体瘤患者的 1a/1b 期临床试验。
Invest New Drugs. 2021 Oct;39(5):1284-1297. doi: 10.1007/s10637-021-01088-4. Epub 2021 Apr 14.
10
Co-Overexpression of TWIST1-CSF1 Is a Common Event in Metastatic Oral Cancer and Drives Biologically Aggressive Phenotype.TWIST1与CSF1共过表达是转移性口腔癌中的常见事件,并驱动生物学侵袭性表型。
Cancers (Basel). 2021 Jan 5;13(1):153. doi: 10.3390/cancers13010153.